Pictet Asset Management (UK)’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $2.79M | Buy |
131,849
+2,460
| +2% | +$52K | ﹤0.01% | 952 |
|
|
2021
Q1 | $3.63M | Buy |
129,389
+6,712
| +5% | +$188K | ﹤0.01% | 890 |
|
|
2020
Q4 | $3.19M | Sell |
122,677
-4,000
| -3% | -$104K | ﹤0.01% | 889 |
|
|
2020
Q3 | $4.71M | Buy |
126,677
+15,293
| +14% | +$568K | 0.01% | 735 |
|
|
2020
Q2 | $5.72M | Buy |
111,384
+7,576
| +7% | +$389K | 0.01% | 648 |
|
|
2020
Q1 | $3.27M | Buy |
103,808
+42,100
| +68% | +$1.33M | 0.01% | 746 |
|
|
2019
Q4 | $3.68M | Buy |
+61,708
| New | +$3.68M | 0.01% | 812 |
|
|
2019
Q2 | – | Sell |
-437,518
| Closed | -$17.6M | – | 1006 |
|
|
2019
Q1 | $17.6M | Buy |
437,518
+52,467
| +14% | +$2.11M | 0.04% | 414 |
|
|
2018
Q4 | $17.7K | Sell |
385,051
-7,262
| -2% | -$334 | 0.04% | 394 |
|
|
2018
Q3 | $17.4M | Buy |
392,313
+46,642
| +13% | +$2.07M | 0.04% | 435 |
|
|
2018
Q2 | $13.5M | Buy |
345,671
+57,117
| +20% | +$2.24M | 0.03% | 451 |
|
|
2018
Q1 | $20.9M | Sell |
288,554
-54,839
| -16% | -$3.97M | 0.05% | 372 |
|
|
2017
Q4 | $22.6M | Buy |
343,393
+36,938
| +12% | +$2.43M | 0.06% | 363 |
|
|
2017
Q3 | $15.4M | Buy |
306,455
+33,574
| +12% | +$1.68M | 0.04% | 413 |
|
|
2017
Q2 | $8.74M | Buy |
272,881
+144,339
| +112% | +$4.62M | 0.03% | 495 |
|
|
2017
Q1 | $4.54M | Buy |
+128,542
| New | +$4.54M | 0.01% | 636 |
|